Cardiovascular Diabetology
Cardiovascular Diabetology is a peer-reviewed open access medical journal covering the intersection of cardiology and diabetology, meaning the connection between diabetes, metabolic syndrome and cardiovascular diseases. It is published by BioMed Central (a part of Springer Nature since 2008) and was established in 2002, with Enrique Fisman (Tel Aviv University) and Alexander Tenenbaum (Sheba Medical Center) as founding editors-in-chief. Articles are published online upon acceptance, rather than in issues. A printed version is periodically distributed in India by Panacea Biotec Ltd.
Discipline | Cardiology, diabetology |
---|---|
Language | English |
Edited by | Enrique Fisman, Alexander Tenenbaum |
Publication details | |
History | 2002-present |
Publisher | |
Yes | |
License | Creative Commons Attribution |
7.332 (2019) | |
Standard abbreviations | |
ISO 4 | Cardiovasc. Diabetol. |
Indexing | |
ISSN | 1475-2840 |
OCLC no. | 848273564 |
Links | |
Scope
Cardiovascular Diabetology considers for publications manuscripts on all aspects of the diabetes/cardiovascular interrelationship, including clinical, genetic, experimental, pharmacological, epidemiological, molecular biology and laboratory research. Most of published articles are original investigations and reviews.
Abstracting and indexing
The journal is abstracted and indexed in Chemical Abstracts Service (CAS), Citebase, Current Contents, Directory of Open Access Journals (DOAJ), EMBASE, MEDLINE/PubMed, Science Citation Index, SCImago Journal Rank, Scopus and Socolar.[1] According to the Journal Citation Reports, the journal has a 2019 impact factor of 7.332, ranking it 11th in the category “Endocrinology & Metabolism” out of 143 journals and 14th in the category "Cardiac & Cardiovascular Systems” out of 138 journals.[2]
References
- "About". BioMed Central. Retrieved 16 October 2020.
- "Cardiovascular Diabetology". 2019 Journal Citation Reports. Web of Science (Science ed.). Clarivate Analytics. 2020.